| Product NDC: | 55154-2722 |
| Proprietary Name: | Geodon |
| Non Proprietary Name: | ziprasidone mesylate |
| Active Ingredient(s): | 20 mg/mL & nbsp; ziprasidone mesylate |
| Administration Route(s): | INTRAMUSCULAR |
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 55154-2722 |
| Labeler Name: | Cardinal Health |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020919 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20031223 |
| Package NDC: | 55154-2722-5 |
| Package Description: | 5 VIAL, SINGLE-DOSE in 1 BAG (55154-2722-5) > 1 mL in 1 VIAL, SINGLE-DOSE |
| NDC Code | 55154-2722-5 |
| Proprietary Name | Geodon |
| Package Description | 5 VIAL, SINGLE-DOSE in 1 BAG (55154-2722-5) > 1 mL in 1 VIAL, SINGLE-DOSE |
| Product NDC | 55154-2722 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | ziprasidone mesylate |
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route Name | INTRAMUSCULAR |
| Start Marketing Date | 20031223 |
| Marketing Category Name | NDA |
| Labeler Name | Cardinal Health |
| Substance Name | ZIPRASIDONE MESYLATE |
| Strength Number | 20 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Atypical Antipsychotic [EPC],Atypical Antipsychotic [EPC] |